Net Income (Loss) Per Share Attributable to Common Stockholders (Tables)

3 Months Ended

Mar. 31, 2026

Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Share

The following table presents the calculation of basic and diluted net income (loss) per share for the Company’s common stock as of:


	Three months ended March 31,
		2026		2025
		(in thousands except per share amounts)

Numerator:
Net income from continuing operations		$	7,171	934
Loss from discontinued operations, net of income tax		—		(8,647)
Net income (loss) attributable to common stockholders.		$	7,171	$	(7,713)

Denominator:
Weighted-average shares of common stock outstanding, basic		177,679		183,468
Weighted-average shares of common stock outstanding, diluted		180,416		185,222

Net income (loss) per share attributable to common stockholders, basic:
Continuing operations		$	0.04	$	0.01
Discontinued operations		—		(0.05)
Net income (loss) per share		$	0.04	$	(0.04)

Net income (loss) per share attributable to common stockholders, diluted:
Continuing operations		$	0.04	$	0.01
Discontinued operations		—		(0.05)
Net income (loss) per share		$	0.04	$	(0.04)

The following table illustrates the reconciliation of the denominators of the basic and diluted EPS computations for income (loss) from continuing operations and loss from discontinued operations, net of income tax.


	Three months ended March 31,
		2026	2025
		(in thousands)
Weighted-average shares of common stock outstanding, basic		177,679	183,468
Shares of common stock subject to outstanding RSUs		882	470
Shares of common stock subject to outstanding options		1,622	1,077
Shares of common stock pursuant to ESPP		233	207
Weighted-average shares of common stock outstanding, diluted		180,416	185,222

Schedule of Antidilutive Outstanding Common Stock Excluded from Computation of Diluted Net Loss Per Share

The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect as of:


	Three months ended March 31,
		2026	2025
		(in thousands)
Outstanding stock options and unvested RSUs		14,494	19,612

Total anti-dilutive outstanding potential common stock		14,494	19,612